Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04455620 |
| Title | BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | BioNTech SE |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Yale Cancer Center | New Haven | Connecticut | 06510 | United States | Details | |
| Sarah Cannon Research Institute at Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| Vall d´Hebron Institute of Oncology (VHIO) | Barcelona | 08035 | Spain | Details | ||
| START Madrid - HM CIOCC | Madrid | 28050 | Spain | Details |